Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectris Regulatory News (SXS)

Share Price Information for Spectris (SXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,142.00
Bid: 3,140.00
Ask: 3,144.00
Change: 16.00 (0.51%)
Spread: 4.00 (0.127%)
Open: 3,154.00
High: 3,172.00
Low: 3,138.00
Prev. Close: 3,126.00
SXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Apr 2020 11:15

RNS Number : 9028I
Spectris PLC
06 April 2020
 

Spectris plc: Director/PDMR Shareholding

 

This notification is made under Article 19(1) of the EU Market Abuse Regulation 596/2014 ("MAR") and relates to the grant of share awards under the terms of the Spectris Long Term Incentive Plan ("LTIP") to persons discharging managerial responsibilities ("PDMRs").

 

On 6 April 2020, Spectris plc (the "Company") was informed that, on the same day, the Executive Directors of the Company accepted awards granted by the Company of nominal-cost share options over ordinary 5p shares on 25 March 2020, pursuant to the terms of the LTIP ("LTIP Awards"), as set out below:

 

Name

Position

Maximum number of shares that may vest under the LTIP Awards granted1

Derek Harding

Chief Financial Officer

59,395

Andrew Heath

Chief Executive

76,276

1. Includes 1.4X multiplier. More details on the performance conditions attached to these LTIP Awards and the multiplier can be found in the Company's 2020 Remuneration Policy

 

The total number of ordinary shares over which these LTIP Awards were accepted on 6 April 2020 represents 0.1% of the Company's issued ordinary share capital on that date.

 

No consideration was paid for the grant of the LTIP Awards.

 

The vesting of these LTIP Awards is subject to the continued employment of the Executive Directors and the satisfaction of performance conditions set by the Remuneration Committee of the Company. The LTIP Awards will normally vest on the later of the third anniversary of grant and the determination of the performance conditions. The Executive Directors' LTIP Awards are then subject to an additional two-year vesting period. To the extent that these LTIP Awards vest, they are exercisable for a period of five years from the end of the additional vesting period.

 

The nominal award price payable by each participant on the exercise of these LTIP Awards is 5 pence per share.

 

While the Remuneration Committee (the "Committee") recognises that the LTIP Awards have been made during a period of market turbulence due to COVID-19, the Committee believes that this is not specific to the Company and the Committee has determined that the price used to calculate the number of shares awarded is appropriate and is consistent with the Company's historic practice.

 

The Committee recognises that there will be a further opportunity to review the appropriateness of the approach taken in the context of further developments during the relevant performance period, to avoid any unacceptable 'windfall' gains. On vesting, the Committee will review this as part of its general consideration of the appropriateness of the formulaic application of the performance conditions.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of MAR and provides further detail:

 

1

Details of the persons discharging managerial responsibilities

a)

Name(s)

Derek Harding

 

2

Reason for the notification

a)

Position/status

Director and PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectris plc

b)

LEI

213800Z4CO2CZO3M3T10

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Option granted over ordinary shares of 5p each

GB0003308607

b)

Nature of the transaction

Acceptance of a grant of a share option over ordinary shares of 5p each on 25 March 2020, pursuant to the terms of the LTIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.05

Nominal-cost option under which a maximum of 59,395 ordinary shares may vest

d)

Aggregated information

Aggregated Volume

n/a

Price

n/a

e)

Date of the transaction

6 April 2020

f)

Place of the transaction

Outside a trading venue

 

 

1

Details of the persons discharging managerial responsibilities

a)

Name(s)

Andrew Heath

 

2

Reason for the notification

a)

Position/status

Director and PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectris plc

b)

LEI

213800Z4CO2CZO3M3T10

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Option granted over ordinary shares of 5p each

GB0003308607

b)

Nature of the transaction

Acceptance of a grant of a share option over ordinary shares of 5p each on 25 March 2020, pursuant to the terms of the LTIP.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.05

 

Nominal-cost option under which a maximum of 76,276 ordinary shares may vest

 

 

 

d)

Aggregated information

Aggregated Volume

n/a

Price

n/a

e)

Date of the transaction

6 April 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

Name of contact and telephone number for queries:

 

Rebecca Dunn

Deputy Company Secretary

01784 470 470

 

For and on behalf of Spectris plc

 

Date: 6 April 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUPUWGCUPUGUQ
Date   Source Headline
10th Jun 20241:58 pmRNSDirector/PDMR Shareholding
4th Jun 20247:00 amRNSSpectris insights - Particle Measuring Systems
3rd Jun 202410:30 amRNSTotal Voting Rights
28th May 20249:55 amRNSDirector/PDMR Shareholding
23rd May 20244:29 pmRNSResult of AGM
15th May 20249:05 amRNSDirector Declaration
9th May 20245:23 pmRNSDirector/PDMR Shareholding
2nd May 20247:00 amRNSQ1 2024 trading update
1st May 20249:50 amRNSTotal Voting Rights
23rd Apr 20245:57 pmRNSDirector/PDMR Shareholding
9th Apr 20243:14 pmRNSDirector/PDMR Shareholding
8th Apr 20245:30 pmRNSHolding(s) in Company
3rd Apr 20246:26 pmRNSTransaction in Own Shares
3rd Apr 20245:20 pmRNSHolding(s) in Company
3rd Apr 20247:00 amRNSDivestment of Red Lion Controls completed
2nd Apr 20246:26 pmRNSTransaction in Own Shares
2nd Apr 202410:30 amRNSTotal Voting Rights
28th Mar 20246:29 pmRNSTransaction in Own Shares
28th Mar 202410:00 amRNSDirectorate Change
27th Mar 20245:56 pmRNSTransaction in Own Shares
27th Mar 20249:45 amRNSAnnual Financial Report
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20246:23 pmRNSTransaction in Own Shares
20th Mar 20246:44 pmRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20245:59 pmRNSTransaction in Own Shares
18th Mar 202411:37 amRNSDirector and Board Committee Membership Change
15th Mar 20246:10 pmRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20246:28 pmRNSTransaction in Own Shares
12th Mar 20246:06 pmRNSTransaction in Own Shares
11th Mar 20246:02 pmRNSTransaction in Own Shares
11th Mar 202412:33 pmRNSDirector/PDMR Shareholding
8th Mar 20246:00 pmRNSTransaction in Own Shares
8th Mar 20242:59 pmRNSDirector/PDMR Shareholding
7th Mar 20245:27 pmRNSTransaction in Own Shares
7th Mar 202411:32 amRNSDirector Declaration
6th Mar 20246:07 pmRNSTransaction in Own Shares
5th Mar 20246:03 pmRNSTransaction in Own Shares
4th Mar 20245:48 pmRNSTransaction in Own Shares
1st Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 202410:00 amRNSTotal Voting Rights
1st Mar 20247:46 amRNSDirector Declaration
29th Feb 20246:02 pmRNSTransaction in Own Shares
29th Feb 20247:00 amRNSFinal Results
28th Feb 20246:05 pmRNSTransaction in Own Shares
27th Feb 20246:04 pmRNSTransaction in Own Shares
26th Feb 20245:59 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.